Literature DB >> 15452832

Invasive aspergillosis in patients with solid tumors.

Norio Ohmagari1, Isaam I Raad, Ray Hachem, Dimitrios P Kontoyiannis.   

Abstract

Invasive aspergillosis (IA) has been reported only rarely among patients with solid tumors. In the current study, the authors retrospectively identified 13 episodes of definite or probable IA (using European Organization for Research and Treatment of Cancer criteria) occurring in patients with solid tumors who were treated between 1994-2003. Nine patients had pulmonary IA and three patients were found to have IA of the brain. Seven patients (54%) had primary or metastatic brain tumors and 6 patients (46%) received systemic steroids within 30 days prior to the diagnosis of IA. The majority of patients (69%) had a lymphocyte count < 500/microL but only 1 patient was neutropenic within the 30 days before the diagnosis of IA was made. Nodular infiltrates and cavities were the most common radiologic findings. Seven patients (54%) responded to antifungal treatment. (c) 2004 American Cancer Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452832     DOI: 10.1002/cncr.20647

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Cerebral aspergillosis within new tumour site presents as incidental new brain lesion in patient receiving temozolomide for glioblastoma multiforme.

Authors:  Shiyuan Anabeth Liu; Timothy Sullivan; Clare Bryce; Amy M Chan; Salvatore Cilmi
Journal:  BMJ Case Rep       Date:  2019-05-31

2.  Pulmonary carcinosarcoma initially presenting as invasive aspergillosis: a case report of previously unreported combination.

Authors:  Ariyo O Olobatoke; Doina David; Wasif Hafeez; Thien Van; Husain A Saleh
Journal:  Diagn Pathol       Date:  2010-01-29       Impact factor: 2.644

3.  Epidemiology of Aspergillosis in Cancer Patients in Taiwan.

Authors:  Chien-An Chen; Chung-Han Ho; Yu-Cih Wu; Yi-Chen Chen; Jhi-Joung Wang; Kuang-Ming Liao
Journal:  Infect Drug Resist       Date:  2022-07-13       Impact factor: 4.177

4.  An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.

Authors:  F Jacobs; D Selleslag; M Aoun; A Sonet; A Gadisseur
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-05       Impact factor: 3.267

5.  Fungal Infections Associated With the Use of Novel Immunotherapeutic Agents.

Authors:  Marilia Bernardes; Tobias M Hohl
Journal:  Curr Clin Microbiol Rep       Date:  2020-09-26

6.  Endobronchial aspergilloma: A case report and literature review.

Authors:  Dongdong Huang; Bing Li; Haiqing Chu; Zhemin Zhang; Qiuhong Sun; Lan Zhao; Liyun Xu; Li Shen; Tao Gui; Huikang Xie; Jun Zhang
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.